Institutional investors purchased a net $407.5 thousand shares of RMD during the quarter ended June 2017 and now own 64.72% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.5 Million shares of ResMed Inc
THE VANGUARD GROUP, INC. Bought 379.0 Thousand shares of ResMed Inc
BLACKROCK ADVISORS LLC Bought 357.2 Thousand shares of ResMed Inc